The Effect of MDZ on Movement During UIA Clipping
- Registration Number
- NCT05553678
- Lead Sponsor
- Seoul National University Hospital
- Brief Summary
This study is a randomized, controlled, double-blinded, and parallel design study. A total 64 patients will be randomized to receive midazolam or normal saline during unruptured intracranial aneurysm clipping surgery.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 64
Inclusion Criteria
- Patients who undergo elective unruptured intracranial aneurysm clipping surgery
- American Society of Anesthesiologists grade 1,2,3
- age > 18 year old
Exclusion Criteria
- Refuse to participate to the study
- Body Mass Index < 18.5 kg/m2 or > 35 kg/m2
- Allergic history of benzodiazepine
- Pregnant
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Control group Normal saline Normal saline (0.03 ml/kg/30 min) will administered during UIA clipping through microscope. treatment group Midazolam Midazolam (0.03 mg/kg/30 min) will administered during UIA clipping through microscope.
- Primary Outcome Measures
Name Time Method Intraoperative movement During microscopic surgery Incidence
- Secondary Outcome Measures
Name Time Method Motor evoked potential amplitude immediately postoperative surgery amplitude
Satisfaction score for intraoperative environment immediately postoperative surgery using 11-point score (0=worst dissatisfied, 10=very sattisfied)
Motor evoked potential Latency immediately postoperative surgery Latency
Duration of ICU stay From date of ICU admission until the date of first discharge from ICU, assessed up to 1 week duration of ICU stay, day
Duration of mechanical ventilation time End of surgery to extubation time duration
Postoperative delirium Postoperative 24 hour Incidence
Trial Locations
- Locations (1)
Seoul National University Bundang Hospital
🇰🇷Seongnam-si, Gyeonggi-do, Korea, Republic of